Carol Meschter, DVM, PhD, DACVP
CEO
Dr. Meschter is a founder of Comparative Biosciences, Inc. Previously, she was in the Investigative Toxicology Group at Hoffmann-LaRoche in Nutley, NJ, and was the Director of the Research Animal Facility at the American Health Foundation in Valhalla, NY. As a board-certified veterinary pathologist, Dr. Meschter brings fifteen years of experience in the pharmaceutical industry, primarily in toxicology, pathology, preclinical development, discovery support, and preclinical pharmacology. She is knowledgeable in early phase drug development from discovery to NDA, with technical expertise in pathology, pharmacology, efficacy modeling, and pharmacokinetics. She is a scientific editorial reviewer for Toxicologic Pathology, Veterinary Pathology, AVMA Journal, AJVR, J Applied Immunology, and has over 100 publications.
James Christenson, PhD
Vice President and Major Program Director
Dr. Christenson is Vice President of Comparative Biosciences, Inc. Previously, he was Director of Antibacterial Research and International Project Director at Hoffmann-LaRoche in Nutley, NJ, and Executive Director of Project Management at Microcide Pharmaceuticals, Inc., in Mountain View, CA. He has over thirty years of experience in the pharmaceutical and contract research industries, primarily in anti-infective drug discovery and development including all phases of drug development from discovery to post-marketing. Dr. Christenson has extensive technical expertise in pharmacokinetics, toxicology, biochemistry, microbiology, assay development, and animal models. He has over 75 publications and patents, and is a scientific editorial reviewer for peer-reviewed publications that include Antimicrobial Agents and Chemotherapy and Clinical and Diagnostic Laboratory Immunology.
Jeanette B. Jacobs, BS
Manager of Quality Assurance
Jeanette B. Jacobs is the Quality Assurance Manager at Comparative Biosciences, Inc. She joined Comparative Biosciences in January 2005. Previously, she worked in Quality Assurance at Progenitor Cell Therapy L.L.C. in Mountain View, CA and in Quality Assurance at Dendreon Corporation in Mountain View, CA. She has over eight years experience in current Good Manufacturing, Clinical and Laboratory Practices (cGMP, cGCP and cGLP) environments, primarily in the Biotechnology field. She has knowledge in preclinical trials as well as Phase I, II, and III of Clinical trials.
Jeanette’s major responsibilities are planning, implementation, and maintenance of the company’s GLP quality assurance systems, programs, and capabilities in which she establishes and maintains quality assurance standards that adhere to FDA requirements. She performs a wide variety of activities to ensure compliance with applicable GLP requirements. Her responsibilities include acting as the Audit representative for audits conducted by clients and regulatory agencies at CBI as well as conducting audits for outside vendors. She monitors and conducts inspections of the critical phases for GLP studies. She is responsible for GLP compliance issues and review of final study reports, which are submitted to the FDA. She maintains the Master schedule for GLP studies as outlined in Title 21 Chapter1 Part 58 and maintains the protocol files for each GLP study. She manages the Corrective Action/Preventative Action (CAPA) systems and ensures that investigations are documented and reported accurately. Her responsibilities also include managing the document control program as well as archiving for all GLP studies conducted at CBI.
Jeanette B. Jacobs earned a BS degree at CSU at Stanislaus, CA in 2001 with concentrations in Genetics, Microbiology, and a minor in Chemistry. She is also a member of the Society of Quality Assurance Specialty Section.
David P. Hernandez
Business Manager
David joined Comparative Biosciences in July, 2006 as the Business Manager. This position also provides operational and organizational support to our company.
David’s major responsibilities are Business Management (tactical and strategic planning, accounting, accounts receivable, accounts payable, cash flow management, capital investment management, operational efficiency monitoring, investments, payroll, and administrative assistance), Purchasing, Facilities (maintenance, improvements, and future needs assessments), and Human Resources (including health care and safety). This position supplies direct support to and an umbrella of operations for the Quality group.
David has 20 years of experience in a wide range of business environments. He has been a Business Manager of an Accountancy and Equity firm, President of his own consulting venture, Plant Managing Director of a semiconductor manufacturing facility, Operations Manager and Product Line Director with full profit and loss responsibility.
David brings his experience and also a strong scientific acumen and curiosity to this position. He earned a degree in Biology (with a chemistry minor) from Stanford University.